The Seoul Administrative Court on Thursday said it has temporarily suspended its decision until July 29 on whether to stop the drug regulator’s order to nullify the license of Kolon Life Science’s gene therapy Invossa-K.
On the same day, the Daejeon District Court also delayed a ruling on the Daejeon Food and Drug Safety Administration’s order to recall and dispose of Invossa injections until July 26.
The suspension of court decisions came after Kolon Life Science filed suits with the Seoul and Daejeon courts against the Ministry of Food and Drug Safety and the Daejeon Food and Drug Safety Administration, to invalidate their administrative orders. The Seoul court is to make the ruling by July 29, and the Daejeon court, by July 26.
“The court’s suspension of decision does not mean that it accepted Kolon’s request to stop the administrative order,” an official at the food and drug safety ministry said.
<© Korea Biomedical Review, All rights reserved.>